Funder will take loss in $7M QRxPharma class action settlement
Article
2020-09-23 3:04 pm
| Sydney
The funder backing a shareholder class action against the directors of pharmaceutical firm QRxPharma will not seek to profit from a $7 million settlement in order to bring about a better return for group members, a judge has been told.
For information on rights and reprints, contact subscriptions@lawyerly.com.au